LivaNova Future Growth

Future criteria checks 3/6

LivaNova is forecast to grow earnings and revenue by 48.1% and 4.4% per annum respectively. EPS is expected to grow by 33.7% per annum. Return on equity is forecast to be 7.7% in 3 years.

Key information

48.1%

Earnings growth rate

33.7%

EPS growth rate

Medical Equipment earnings growth18.3%
Revenue growth rate4.4%
Future return on equity7.7%
Analyst coverage

Good

Last updated31 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BOVESPA:L2IV34 - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,386121299N/A10
12/31/20251,31241476N/A10
12/31/20241,2450729N/A10
9/30/20241,24224109158N/A
6/30/20241,210-1785125N/A
3/31/20241,185-323064N/A
12/31/20231,154184075N/A
9/30/20231,1183840N/A
6/30/20231,085-972957N/A
3/31/20231,045-823665N/A
12/31/20221,022-864370N/A
9/30/20221,017-936085N/A
6/30/20221,018-295173N/A
3/31/20221,028-10286109N/A
12/31/20211,035-13677103N/A
9/30/20211,035-41482106N/A
6/30/20211,022-3855991N/A
3/31/2021939-4171146N/A
12/31/2020934-347-114-79N/A
9/30/2020952-208-150-114N/A
6/30/2020981-161-234-199N/A
3/31/20201,076-102-230-199N/A
12/31/20191,084-158-116-91N/A
9/30/20191,094-222-106-73N/A
6/30/20191,097-2601955N/A
3/31/20191,107-21163102N/A
12/31/20181,107-17882120N/A
9/30/20181,088082117N/A
6/30/20181,06833N/A108N/A
3/31/20181,03659N/A79N/A
12/31/20171,01254N/A91N/A
9/30/2017795121N/A114N/A
6/30/201784092N/A109N/A
3/31/201790555N/A114N/A
12/31/20169652N/A90N/A
12/31/2015545-22N/A-14N/A
10/18/201529514N/A87N/A
7/24/201530157N/A80N/A
4/24/201529258N/A80N/A
1/23/201529266N/A80N/A
10/24/201428863N/A75N/A
7/25/201428560N/A63N/A
4/25/201428255N/A54N/A
1/24/201427648N/A61N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: L2IV34's forecast earnings growth (48.1% per year) is above the savings rate (10.4%).

Earnings vs Market: L2IV34's earnings (48.1% per year) are forecast to grow faster than the BR market (13.2% per year).

High Growth Earnings: L2IV34's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: L2IV34's revenue (4.4% per year) is forecast to grow slower than the BR market (7.6% per year).

High Growth Revenue: L2IV34's revenue (4.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: L2IV34's Return on Equity is forecast to be low in 3 years time (7.7%).


Discover growth companies